SKI Market

A+| A| A-|

Indian Indices

Sensex

75,315.04 77.05
( 0.10%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

60,874.73 -534.56
(-0.87%)

Nikkei 225

10,297.25 101.88
(1.00%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

375.7898972

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

34.65

111589.46

EPS(TTM)

Face Value()

Div & Yield %

38.58

0.6

Back

nexome capital markets ltd

PCBL Chemical consolidated net profit declines 97.82% in the December 2025 quarter

Feb 03,2026

Net profit of PCBL Chemical declined 97.82% to Rs 2.03 crore in the quarter ended December 2025 as against Rs 93.05 crore during the previous quarter ended December 2024. Sales declined 8.18% to Rs 1845.62 crore in the quarter ended December 2025 as against Rs 2010.00 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1845.62	2010.00	-8
OPM %	11.63	15.79	-
PBDT	124.44	210.71	-41
PBT	30.81	124.05	-75
NP	2.03	93.05	-98

75,315.04 77.05 ( 0.10%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

60,874.73 -534.56 (-0.87%)

10,297.25 101.88 (1.00%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)